Effect of Sham Feeding on Postoperative Ileus After Elective Liver Transplantation

Postoperative Ileus Clinical Trial

Official title:

Effect of Sham Feeding on Postoperative Ileus After Elective Liver Transplantation

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01956643
• Other study ID #: ShamLT
• Status: Completed
• Phase: N/A
• Start date: October 2013
• Est. completion date: September 2014

Study information

• Verified date: September 2019
• Source: Seoul National University Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Postoperative ileus is a common after abdominal surgery. Multifactorial etiology such as surgical trauma, bowel manipulation and perioperative opioids contributes to delayed return of normal gut function Chewing gum has recently been used as a form of sham feeding to stimulate acceleration of gut function after abdominal surgery.

The investigators hypothesize that sham feeding with chewing gum will accelerate return of gut function after liver transplantation.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 70
• Est. completion date: September 2014
• Est. primary completion date: September 2014
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

• elective liver transplantation surgery

• an ability to chew gum

Exclusion Criteria:

• emergency surgery

• age less than 18 years,

• inability to provide written informed consent

• an inability to chew gum

• hepaticojejunostomy

• sedated patients

• reintubated patients

• Glasgow Coma Scale <13

• reoperation before gas out

• previous bowel surgery

Related Conditions & MeSH terms

• Ileus
• Postoperative Ileus

Intervention

Other:
• gum chewing
gum chewing
• Control
Routine care during NPO

Locations

Country	Name	City	State
Korea, Republic of	Seoul National University Hospital	Seoul

Sponsors (1)

Lead Sponsor	Collaborator
Seoul National University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	time to flatus		an expected average of 75 hours
Secondary	percentage of target calories		an average 4 days
Secondary	ICU length of stay		an average 96 hous
Secondary	hospital length of stay		an average 20 days